MEDI2045 (anti-IL-4Ra) is a high-affinity human and Cynomolgus cross-reactive antibody that blocks the functional interaction of IL-4 and IL-13 with their obligate receptor, IL-4Ra. MEDI2045 (anti-IL-4Ra) has the potential to treat severe, uncontrolled asthma.
Specification: Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB209762-SCI_1bfa4de50a353d330ba4c1286a6b85cc.pdf
- UPC:
- 51111746
- Condition:
- New
- Availability:
- 4-8 weeks
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab209762-1mg
- Product Size:
- 1mg